Telix Pharmaceuticals Limited Dividend 2022

Telix Pharmaceuticals Limited (TLX) is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or molecularly-targeted radiation. TLX is headquartered in Melbourne with international operations in Brussels, Kyoto and Indianapolis. TLX is developing a portfolio of clinical-stage oncology products that address significant unmet medical need in renal, prostate and brain (glioblastoma) cancer.

Telix Pharmaceuticals Limited operators in Health Care sector and under industry of Biotechnology. The company website is:

You can also check out dividend history for similar stocks in the same sector as follows:

TLX Dividend Dates

Please click the table header to sort the data.

No Dividend Dates Found